AS

Afreen Siddiqui

Active Director Director DIN 09598401
DIN 09598401 First appointment May 2022 Primary industry Home Appliances
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Afreen Siddiqui

Data last updated:

Afreen Siddiqui is a Director at Wakils Pharmaceuticals Private Limited (since 2022). The company operates in Home Appliances. Wakils Pharmaceuticals Private Limited reported revenue of ₹1.44 Cr (FY 2025).

DIN 09598401
Primary Designation Director
Industry Home Appliances
First Appointment 07 May 2022
Oldest Company Age 4 yrs
Largest company Wakils Pharmaceuticals Private Limited · ₹1.44 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 May 20222022₹1.44 Cr (FY 2025)Active

Board colleagues of Afreen Siddiqui

Directorship timeline

Open interactive timeline →
Wakils Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Afreen Siddiqui

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Afreen Siddiqui

Afreen Siddiqui currently holds 1 directorship: Wakils Pharmaceuticals Private Limited (Director, since 07 May 2022, revenue ₹1.44 Cr (FY 2025)).

Afreen Siddiqui was first appointed on 07 May 2022 as Director at Wakils Pharmaceuticals Private Limited.

The current boards of Afreen Siddiqui's companies include Farha Ahmed (Wakils Pharmaceuticals Private Limited), Sajid Ahmed (Wakils Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available